Brief: U.S. FDA Advisers Vote 17-0 In Favor Of Recommending The Agency Approve Over-The-Counter Use Of Perrigo's Birth Control Pill
May 10 (Reuters) - U.S. FDA:
* U.S. FDA ADVISERS VOTE 17-0 IN FAVOR OF RECOMMENDING THE
AGENCY
APPROVE OVER-THE-COUNTER USE OF PERRIGO'S BIRTH CONTROL PILL
Further company coverage: PRGO.N
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Perrigo
See all newsPerrigo to pay $10 million to settle US class action over baby formula prices
Perrigo Company PLC reports results for the quarter ended June 30 - Earnings Summary
Brief: Perrigo Company Reaffirms Full-Year 2026 Outlook
Ireland's Perrigo Q2 profit beats on portfolio streamlining
Brief: Perrigo Company - Declares QTRLY Dividend Of $0.29 Per Share